TAI · 6861.TW
InnoCare Optoelectronics Corporation
NT$213.50-NT$19.00 (-8.17%)
InnoCare Optoelectronics Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.43% below the high.
Loading market information…
TWO · 4138.TWO · TWD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:24 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Dynamic Medical Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 19.79% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Dynamic Medical Technologies Inc.’s forward annual dividend is NT$4.20 per share, paid annual. The forward yield is 7.68% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Dynamic Medical Technologies Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Dynamic Medical Technologies Inc., encompassing its various subsidiaries, operates within the aesthetic industry throughout Taiwan and Hong Kong. The company's primary focus involves the commercialization and upkeep of cosmetic laser and light-based equipment. Its extensive product range, which it both distributes and sells, includes specialized aesthetic medical instruments, body sculpting technologies, injectable dermal fillers, and high-grade cosmeceuticals, alongside a diverse selection of beauty treatment and cosmetic items. Additionally, Dynamic Medical Technologies delivers professional services such as training for aestheticians and consultation for clinical operational efficiency. The company is organized into distinct segments: Dynamic, Hong Kong Dynamic, Excelsior Beauty, and CYJ. Established in 1992, its main operational hub is situated in New Taipei City, Taiwan.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$213.50-NT$19.00 (-8.17%)
InnoCare Optoelectronics Corporation’s quoted price sits in the lower half of its reported 52-week range, 56.43% below the high.
NT$26.95+NT$0.55 (+2.08%)
Intech Biopharm Corporation’s quoted price sits in the lower half of its reported 52-week range, 36.56% below the high.
NT$5.22-NT$0.26 (-4.74%)
Medtecs International Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 26.48% below the high.
NT$21.00-NT$0.05 (-0.24%)
Maywufa Company Ltd.’s quoted price sits in the upper half of its reported 52-week range, 5.83% below the high.
NT$73.00-NT$1.10 (-1.48%)
A Plus Biotechnology Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 20.65% below the high.
NT$26.40-NT$0.40 (-1.49%)
Taiwan Bio Therapeutics Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 19.76% below the high.
NT$43.30-NT$0.30 (-0.69%)
HeXun Biosciences Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.53% below the high.
NT$50.00-NT$0.50 (-0.99%)
MedFirst Healthcare Services, Inc.’s quoted price sits in the lower half of its reported 52-week range, 20.26% below the high.
